Andlauer Healthcare Group (TSE:AND – Free Report) had its price objective trimmed by TD Securities from C$53.00 to C$51.00 in a research report report published on Tuesday morning,BayStreet.CA reports. The firm currently has a buy rating on the stock.
A number of other research firms have also commented on AND. Stifel Nicolaus upped their price target on Andlauer Healthcare Group from C$50.00 to C$52.00 in a research report on Monday, February 24th. National Bankshares upped their target price on Andlauer Healthcare Group from C$45.00 to C$49.00 and gave the company a “sector perform” rating in a report on Tuesday, February 11th. Finally, Scotiabank cut their price target on shares of Andlauer Healthcare Group from C$44.50 to C$43.00 and set a “sector perform” rating on the stock in a report on Wednesday, April 2nd. Three equities research analysts have rated the stock with a hold rating and four have issued a buy rating to the company’s stock. According to data from MarketBeat.com, Andlauer Healthcare Group currently has an average rating of “Moderate Buy” and a consensus target price of C$48.29.
Check Out Our Latest Analysis on AND
Andlauer Healthcare Group Stock Performance
Andlauer Healthcare Group Increases Dividend
The business also recently announced a quarterly dividend, which was paid on Tuesday, April 15th. Stockholders of record on Tuesday, April 15th were issued a $0.12 dividend. This represents a $0.48 annualized dividend and a dividend yield of 1.19%. The ex-dividend date of this dividend was Monday, March 31st. This is an increase from Andlauer Healthcare Group’s previous quarterly dividend of $0.11. Andlauer Healthcare Group’s payout ratio is 24.09%.
Andlauer Healthcare Group Company Profile
Andlauer Healthcare Group Inc, a supply chain management company, provides a platform of customized third-party logistics (3PL) and specialized transportation solutions for the healthcare sector in Canada and the United States. The company operates in two segments, Specialized Transportation and Healthcare Logistics.
See Also
- Five stocks we like better than Andlauer Healthcare Group
- 3 Must-Buy Warren Buffett Stocks for Volatile Times
- Beware of BigBear.ai: Insiders Are Selling—Should You?
- Stock Analyst Ratings and Canadian Analyst Ratings
- CrowdStrike Stock is a Buy as Cyberthreat Environment Expands
- Investing in the High PE Growth Stocks
- Congress! Who Traded What During the Tariff-Induced MeltdownÂ
Receive News & Ratings for Andlauer Healthcare Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Andlauer Healthcare Group and related companies with MarketBeat.com's FREE daily email newsletter.